Identification of DNA gyrase a mutations in ciprofloxacin-resistant isolates of Salmonella typhimurium from men and cattle in Germany

被引:48
作者
Heisig, P
Kratz, B
Halle, E
Graser, Y
Altwegg, M
Rabsch, W
Faber, JP
机构
[1] BEREICH MED CHARITE,D-10117 BERLIN,GERMANY
[2] UNIV ZURICH,CH-8028 ZURICH,SWITZERLAND
[3] BUNDESINST GESUNDHEITLICHEN VERBRAUCHERSCHUTZ,D-38843 WERNIGERODE,GERMANY
[4] VET MED BEREICH WERNIGERODE,D-38843 WERNIGERODE,GERMANY
[5] UNIV BONN,D-53127 BONN,GERMANY
来源
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE | 1995年 / 1卷 / 03期
关键词
D O I
10.1089/mdr.1995.1.211
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Six multiply resistant isolates of Salmonella typhimurium var. copenhagen with high-level resistance to fluoroquinolones (e.g., MIC of ciprofloxacin: 32 mu g/ml) were isolated from human patients (n = 3) and from cattle (n = 3). The isolates were examined by complementation tests using a set of broad-host-range plasmids, which carry either the gyrA(+) or the gyrB(+) genes or a combination of both from Escherichia coli K-12. The results indicated a combination of gyrA and gyrB mutations in all isolates. Subsequent direct sequencing of PCR-generated internal DNA fragments of gyrA revealed an identical double mutation in all six isolates (Ser-83 --> Ala and Asp-87 --> Asn). In addition, the results of phenotypic (i.e., phagetype, biotype, serotype) and genotypic characterization [i.e., ribotyping and polymerase chain reaction fingerprinting (PCR-fingerprinting)] were identical for all six isolates and were distinguishable from a quinolone-susceptible strain of the same serovar and an unrelated isolate of S. typhimurium. These data indicate the clonal identity of the fluoroquinolone-resistant strains of S. typhimurium isolated from men and cattle in Germany.
引用
收藏
页码:211 / 218
页数:8
相关论文
共 48 条
[1]   BACTERIOPHAGE-TYPING DESIGNATIONS OF SALMONELLA-TYPHIMURIUM [J].
ANDERSON, ES ;
WARD, LR ;
DESAXE, MJ ;
DESA, JDH .
JOURNAL OF HYGIENE, 1977, 78 (02) :297-300
[2]  
Ausubel FM., 1995, MOL REPROD DEV, V3rd edn, DOI DOI 10.1002/MRD.1080010210
[3]  
BAQUAR N, 1993, FEMS MICROBIOL LETT, V112, P217, DOI [10.1111/j.1574-6968.1993.tb06451.x, 10.1016/0378-1097(93)90167-Z]
[4]  
BAUERFEIND R, 1992, BERL MUNCH TIERARZTL, V105, P38
[5]  
BAUERNFEIND R, 1994, J ANTIMICROB CHEMOTH, V34, P1074
[6]   USE OF RIBOTYPING IN EPIDEMIOLOGIC SURVEILLANCE OF NOSOCOMIAL OUTBREAKS [J].
BINGEN, EH ;
DENAMUR, E ;
ELION, J .
CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (03) :311-327
[7]   CONSTRUCTION AND FINE MAPPING OF RECOMBINANT PLASMIDS CONTAINING THE RRNB RIBOSOMAL-RNA OPERON OF ESCHERICHIA-COLI [J].
BROSIUS, J ;
ULLRICH, A ;
RAKER, MA ;
GRAY, A ;
DULL, TJ ;
GUTELL, RR ;
NOLLER, HF .
PLASMID, 1981, 6 (01) :112-118
[8]   NOVEL GYRA POINT MUTATION IN A STRAIN OF ESCHERICHIA-COLI RESISTANT TO FLUOROQUINOLONES BUT NOT TO NALIDIXIC-ACID [J].
CAMBAU, E ;
BORDON, F ;
COLLATZ, E ;
GUTMANN, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1247-1252
[9]   EPIDEMIOLOGY OF DRUG-RESISTANCE - IMPLICATIONS FOR A POSTANTIMICROBIAL ERA [J].
COHEN, ML .
SCIENCE, 1992, 257 (5073) :1050-1055
[10]   DNA TOPOISOMERASES [J].
GELLERT, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1981, 50 :879-910